drugset / Trial / NCT03264781

The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users

NCT03264781

Phase 1/2 Unknown 44 enrolled Chulalongkorn University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine that once-a-month injectable contraceptive( Cyclofem® ) has the effect on treatment of irregular uterine bleeding in implant contraceptive users or not.

Timeline

Start
2016-08
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Cypionate Small molecule 5 mg Intramuscular
Subject medroxyprogesterone acetate Other / unclassified 25 mg Intramuscular

Indications